Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarabjit Chadha

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Indian Journal of Tuberculosis|August 24, 2019
Byssinosis and tuberculosis amongst "home-based" powerloom workers in Madhya Pradesh State, IndiaSarabjit Chadha, Debashish Kundu, Karuna Sagili, et al.
BMC Research Notes|October 27, 2015
Light Emitting Diode Fluorescence Microscopy increased the detection of smear-positives during follow-up of Tuberculosis patients in India: program implicationsBadri Thapa, Lord Wasim Reza, Ajay Mv Kumar, et al.
Health Economics Review|January 29, 2018
Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, IndiaDebashish Kundu, Nandini Sharma, Sarabjit Chadha, et al.
The Indian Journal of Tuberculosis|May 29, 2016
Innovatively addressing the challenge of maintaining binocular microscopes under Tuberculosis Programme in India - Is this feasible?Sarabjit Chadha, Sharath Burugina Nagaraja, Banaru Muralidhara Prasad, et al.
Tuberculosis Research and Treatment|May 30, 2018
Is Chemoprophylaxis for Child Contacts of Drug-Resistant TB Patients Beneficial? A Systematic ReviewC Padmapriyadarsini, Mrinalini Das, Sharath Burugina Nagaraja, et al.
International Journal for Equity in Health|March 28, 2012
Addressing poverty through disease control programmes: examples from Tuberculosis control in IndiaVishnu Vardhan Kamineni, Nevin Wilson, Anand Das, et al.
Tuberculosis Research and Treatment|August 29, 2017
TB Notification from Private Health Sector in Delhi, India: Challenges Encountered by Programme Personnel and Private Health Care ProvidersMahasweta Satpati, Sharath Burugina Nagaraja, Hemant Deepak Shewade, et al.
Plos One|January 30, 2010
Risk factors for treatment default among re-treatment tuberculosis patients in India, 2006Ugra Mohan Jha, Srinath Satyanarayana, Puneet K Dewan, et al.
Plos One|November 30, 2023
Optimizing diagnostic networks to increase patient access to TB diagnostic services: Development of the diagnostic network optimization (DNO) approach and learnings from its application in Kenya, India and the PhilippinesHeidi Albert, Sidharth Rupani, Enos Masini, et al.
Plos One|October 3, 2012
Is one sputum specimen as good as two during follow-up cultures for monitoring multi drug resistant tuberculosis patients in India?Sharath Burugina Nagaraja, Ajay M V Kumar, Kuldeep Singh Sachdeva, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Indian Journal of Tuberculosis|August 24, 2019
Byssinosis and tuberculosis amongst "home-based" powerloom workers in Madhya Pradesh State, IndiaSarabjit Chadha, Debashish Kundu, Karuna Sagili, et al.
BMC Research Notes|October 27, 2015
Light Emitting Diode Fluorescence Microscopy increased the detection of smear-positives during follow-up of Tuberculosis patients in India: program implicationsBadri Thapa, Lord Wasim Reza, Ajay Mv Kumar, et al.
Health Economics Review|January 29, 2018
Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, IndiaDebashish Kundu, Nandini Sharma, Sarabjit Chadha, et al.
The Indian Journal of Tuberculosis|May 29, 2016
Innovatively addressing the challenge of maintaining binocular microscopes under Tuberculosis Programme in India - Is this feasible?Sarabjit Chadha, Sharath Burugina Nagaraja, Banaru Muralidhara Prasad, et al.
Tuberculosis Research and Treatment|May 30, 2018
Is Chemoprophylaxis for Child Contacts of Drug-Resistant TB Patients Beneficial? A Systematic ReviewC Padmapriyadarsini, Mrinalini Das, Sharath Burugina Nagaraja, et al.
International Journal for Equity in Health|March 28, 2012
Addressing poverty through disease control programmes: examples from Tuberculosis control in IndiaVishnu Vardhan Kamineni, Nevin Wilson, Anand Das, et al.
Tuberculosis Research and Treatment|August 29, 2017
TB Notification from Private Health Sector in Delhi, India: Challenges Encountered by Programme Personnel and Private Health Care ProvidersMahasweta Satpati, Sharath Burugina Nagaraja, Hemant Deepak Shewade, et al.
Plos One|January 30, 2010
Risk factors for treatment default among re-treatment tuberculosis patients in India, 2006Ugra Mohan Jha, Srinath Satyanarayana, Puneet K Dewan, et al.
Plos One|November 30, 2023
Optimizing diagnostic networks to increase patient access to TB diagnostic services: Development of the diagnostic network optimization (DNO) approach and learnings from its application in Kenya, India and the PhilippinesHeidi Albert, Sidharth Rupani, Enos Masini, et al.
Plos One|October 3, 2012
Is one sputum specimen as good as two during follow-up cultures for monitoring multi drug resistant tuberculosis patients in India?Sharath Burugina Nagaraja, Ajay M V Kumar, Kuldeep Singh Sachdeva, et al.
Pageof 2